P2.101 Efflcacy and safety of preladenant, a novel A2A receptor antagonist, as a levodopa adjunct in patients with moderate-to-severe Parkinson's disease
Title:
P2.101 Efflcacy and safety of preladenant, a novel A2A receptor antagonist, as a levodopa adjunct in patients with moderate-to-severe Parkinson's disease
Author:
Hauser, R.A. Pourcher, E. Micheli, F. Mok, V. Onofrj, M. Huyck, S.B. Wolski, K.P. Cantillon, M.